AGLAEAPHARMA Trademark

Trademark Overview


On Wednesday, August 23, 2023, a trademark application was filed for AGLAEAPHARMA with the United States Patent and Trademark Office. The USPTO has given the AGLAEAPHARMA trademark a serial number of 98146484. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 11, 2025. This trademark is owned by AGLAEAPHARMA, INC.. The AGLAEAPHARMA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical research; Pharmaceutical research and development

Antiallergic medicines; Effervescent analgesic pharmaceutical preparations; Medicinal syrups for the treatment of pain, glaucoma and tumors; Medicines for dental purposes; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoim...
aglaeapharma

General Information


Serial Number98146484
Word MarkAGLAEAPHARMA
Filing DateWednesday, August 23, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2025

Trademark Statements


Goods and ServicesMedical research; Pharmaceutical research and development
Pseudo MarkAGLAEA PHARMA; AGLAEA PHARMACEUTICAL
Goods and ServicesAntiallergic medicines; Effervescent analgesic pharmaceutical preparations; Medicinal syrups for the treatment of pain, glaucoma and tumors; Medicines for dental purposes; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of pain, glaucoma and tumors; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Veterinary preparations, namely, pain relief medication; Pharmaceutical preparations for treating hypertension

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, September 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 24, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAGLAEAPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCamden City, DE 19934

Party NameAGLAEAPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCamden City, DE 19934

Trademark Events


Event DateEvent Description
Saturday, August 26, 2023NEW APPLICATION ENTERED
Sunday, September 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 24, 2024ASSIGNED TO EXAMINER
Wednesday, April 24, 2024SUSPENSION LETTER WRITTEN
Wednesday, April 24, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, April 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 27, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, March 28, 2025ASSIGNED TO EXAMINER
Saturday, August 16, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, August 19, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 10, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 10, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT